Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock, Intensive Care Medicine, vol.43, issue.3, pp.304-377, 2016. ,
Implications of augmented renal clearance in critically ill patients, Nature Reviews Nephrology, vol.7, pp.539-582, 2011. ,
Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia, European Journal of Clinical pharmacology, vol.71, pp.75-83, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01079022
Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole, Antimicrobial Agents and Chemotherapy, vol.53, pp.3294-301, 2009. ,
A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance, Critical Care, vol.15, p.139, 2011. ,
Glomerular hyperfiltration: definitions, mechanisms and clinical implications, Nature reviews Nephrology, vol.8, pp.293-300, 2012. ,
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, Lancet Infectious Diseases, vol.14, pp.498-509, 2014. ,
KDIGO clinical practice guidelines for acute kidney injury, Nephron Clinical practice, vol.120, pp.179-84, 2012. ,
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams, Critical Care, vol.15, p.206, 2011. ,
, Évaluation de la fonction rénale et de la protéinurie pour le diagnostic de la maladie rénale chronique chez l'adulte. Recommandations pour la pratique clinique, Nephrologie & Therapeutique, vol.5, pp.302-307, 2009.
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), Journal of the American Medical Association, vol.315, pp.775-87, 2016. ,
Sepsis in European intensive care units: results of the SOAP study, Critical Care Medicine, vol.34, pp.344-53, 2006. ,
Epidemiologic trends of sepsis in western countries, Annals of Translational Medicine, vol.4, p.325, 2016. ,
Septic shock, Lancet, vol.365, pp.63-78, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01414960
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Critical Care Medicine, vol.34, pp.1589-96, 2006. ,
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia, Intensive Care Medicine, vol.29, pp.2170-2173, 2003. ,
Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy, Clinical Infectious Diseases, vol.23, pp.486-94, 1996. ,
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting, Chest, vol.118, pp.146-55, 2000. ,
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients, Chest, vol.115, pp.462-74, 1999. ,
Drotrecogin alfa (activated) in adults with septic shock, New England Journal of Medicine, vol.366, pp.2055-64, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00865183
Intensive versus conventional glucose control in critically ill patients, New England Journal of Medicine, vol.360, pp.1283-97, 2009. ,
Hydrocortisone therapy for patients with septic shock, New England Journal of Medicine, vol.358, pp.111-135, 2008. ,
Intensity of continuous renal-replacement therapy in critically ill patients, New England Journal of Medicine, vol.361, pp.1627-1665, 2009. ,
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial, Clinical Infectious Diseases, vol.38, pp.284-292, 2004. ,
Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis, International Journal of Antimicrobial Agents, vol.26, pp.50-55, 2005. ,
Nanomechanics of the endothelial glycocalyx in experimental sepsis, PloS One, vol.8, p.80905, 2013. ,
Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy, British Journal of Anaesthesia, vol.108, pp.384-94, 2012. ,
Sepsis and endothelial permeability, New England Journal of Medicine, vol.363, pp.689-91, 2010. ,
A positive fluid balance is associated with a worse outcome in patients with acute renal failure, Critical Care, vol.12, p.74, 2008. ,
Aminoglycoside volume of distribution and illness severity in critically ill septic patients, Anaesthesia and Intensive Care, vol.21, pp.172-175, 1993. ,
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens, Antimicrobial Agents and Chemotherapy, vol.55, pp.2704-2713, 2011. ,
Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis, Antimicrobial Agents and Chemotherapy, vol.50, pp.2455-63, 2006. ,
Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment, Intensive Care Medicine, vol.33, pp.1018-1042, 2007. ,
Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature, Clinical Therapeutics, vol.38, pp.1976-94, 2016. ,
Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study, Critical Care, vol.18, p.632, 2014. ,
beta-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study, International Journal of Antimicrobial Agents, vol.45, pp.278-82, 2015. ,
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study, British Medical Journal, vol.333, p.1044, 2006. ,
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients, Clinical Pharmacokinetics, vol.50, pp.99-110, 2011. ,
Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury, Lancet, vol.1, pp.781-785, 1985. ,
How monitoring of the microcirculation may help us at the bedside, Current Opinion in Critical Care, vol.11, pp.240-244, 2005. ,
Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap, Clinical Infectious Diseases, vol.51, issue.1, pp.103-113, 2010. ,
Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?, Critical Care Medicine, vol.37, pp.926-959, 2009. ,
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock, Critical Care Medicine, vol.29, pp.385-91, 2001. ,
Glomerular hyperfiltration and the salt paradox in early [corrected] type 1 diabetes mellitus: a tubulo-centric view, Journal of the American Society of Nephrology, vol.14, pp.530-537, 2003. ,
The effects of weight loss on renal function in patients with severe obesity, Journal of the American Society of Nephrology, vol.14, pp.1480-1486, 2003. ,
Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension, Journal of the American Society of Nephrology, vol.8, pp.893-900, 1997. ,
Glomerular ultrafiltration in normal and preeclamptic pregnancy, Journal of the American Society of Nephrology, vol.14, pp.648-52, 2003. ,
Single-Nephron Glomerular Filtration Rate in Healthy Adults, New England Journal of Medicine, vol.376, pp.2349-57, 2017. ,
Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin, New England Journal of Medicine, vol.299, pp.915-924, 1978. ,
Creatinine clearance in renal disease. A reappraisal, British Medical Journal, vol.4, pp.11-15, 1969. ,
Comparison of different equations to assess glomerular filtration in critically ill patients, Intensive care medicine, vol.41, pp.427-462, 2015. ,
Validation of a continuous infusion of low dose Iohexol to measure glomerular filtration rate: randomised clinical trial, Journal of Translational Medicine, vol.13, p.58, 2015. ,
Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C, International Journal of Antimicrobial Agents, vol.18, pp.545-553, 2010. ,
Cefepime versus cefpirome: the importance of creatinine clearance, Anesthesia and Analgesia, vol.97, pp.1149-54, 2003. ,
Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations, Chest, vol.142, pp.30-39, 2012. ,
ARC--augmented renal clearance, Current Pharmaceutical Biotechnology, vol.12, pp.2020-2029, 2011. ,
Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy, Journal of Critical Care, vol.28, pp.695-700, 2013. ,
Augmented renal clearance, low beta-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study, International Journal of Antimicrobial Agents, vol.45, pp.385-92, 2015. ,
Association between augmented renal clearance and clinical outcomes in patients receiving beta-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial, International Journal of Antimicrobial Agents, vol.49, pp.624-654, 2017. ,
A critical appraisal for definition of hyperfiltration, American Journal of Kidney Diseases, vol.43, pp.396-403, 2004. ,
Augmented renal clearance in the ICU: results of a multicenter observational study of renal function in critically ill patients with normal plasma creatinine concentrations, Critical Care Medicine, vol.42, pp.520-527, 2014. ,
Glomerular hyperfiltration and albuminuria in critically ill patients, Anaesthesia and intensive care, vol.36, pp.674-80, 2008. ,
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients, Critical Care, vol.17, p.35, 2013. ,
,
, Revista Brasileira de Terapia Intensiva, vol.26, pp.13-20, 2014.
Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine, Intensive Care Medicine, vol.40, pp.1795-815, 2014. ,
Norepinephrine and vital organ blood flow, Intensive Care Medicine, vol.28, pp.1804-1813, 2002. ,
Renal transport of antibiotics and nephrotoxicity: a review, Journal of Chemotherapy, vol.13, pp.461-72, 2001. ,
Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients, Intensive care medicine, vol.32, pp.2063-2069, 2006. ,
Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study, Critical Care, vol.15, p.49, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663861
Augmented renal clearance in septic patients and implications for vancomycin optimisation, International Journal of Antimicrobial Agents, vol.39, pp.420-423, 2012. ,
High creatinine clearance in critically ill patients with community-acquired acute infectious meningitis, BMC Nephrology, vol.13, p.124, 2012. ,
Augmented renal clearance in the critically ill: how to assess kidney function, Annals of Pharmacotherapy, vol.46, pp.952-961, 2012. ,
Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin, Journal of Clinical Pharmacy and Therapeutics, vol.38, pp.462-469, 2013. ,
Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients, Journal of Nephrology, vol.27, pp.403-413, 2014. ,
Select critically ill patients at risk of augmented renal clearance: experience in a Malaysian intensive care unit, Anaesthesia and Intensive Care, vol.42, pp.715-737, 2014. ,
Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?, Critical Care, vol.19, p.28, 2015. ,
Epidemiology of augmented renal clearance in mixed ICU patients, Minerva Anestesiologica, vol.81, pp.1079-85, 2015. ,
Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage, Neurocritical Care, vol.23, pp.374-383, 2015. ,
Augmented renal clearance in Japanese intensive care unit patients: a prospective study, Journal of Intensive Care, vol.4, p.62, 2016. ,
Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance, Journal of Neurotrauma, vol.34, pp.137-181, 2017. ,
International study of the prevalence and outcomes of infection in intensive care units, Journal of the American Medical Association, vol.302, pp.2323-2332, 2009. ,
DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients, Clinical Infectious Diseases, vol.58, pp.1072-83, 2014. ,
Antibiotic resistance--what's dosing got to do with it?, Critical Care Medicine, vol.36, pp.2433-2473, 2008. ,
Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia, Clinical Infectious Diseases, vol.57, pp.1568-76, 2013. ,
Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis, Journal of Antimicrobial Chemotherapy, vol.52, pp.668-74, 2003. ,
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections, International Journal of Antimicrobial Agents, vol.31, pp.345-51, 2008. ,
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections, Antimicrobial agents and chemotherapy, vol.51, pp.1725-1755, 2007. ,
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients, Antimicrobial Agents and Chemotherapy, vol.37, pp.1073-81, 1993. ,
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock, International Journal of Antimicrobial Agents, vol.41, pp.255-60, 2013. ,
Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme, Clinical Pharmacokinetics, vol.42, pp.1411-1434, 2003. ,
Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia, Antimicrobial Agents and Chemotherapy, vol.56, pp.130-136, 2012. ,
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a costeffectiveness analysis, Therapeutic Drug Monitoring, vol.21, pp.63-73, 1999. ,
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia, European Respiratory Journal, vol.34, pp.394-400, 2009. ,
Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia, Journal of Antimicrobial Chemotherapy, vol.68, pp.900-906, 2013. ,
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections, Antimicrobial Agents and Chemotherapy, vol.45, pp.2793-2800, 2001. ,
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections, Clinical Pharmacokinetics, vol.43, pp.925-967, 2004. ,
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target, Antimicrobial Agents and Chemotherapy, vol.56, pp.2795-805, 2012. ,
Therapeutic drug monitoring of antibiotics, Lancet Infectious Diseases, vol.14, pp.1180-1181, 2014. ,
Pharmacokinetic issues for antibiotics in the critically ill patient, Critical Care Medicine, vol.37, pp.840-51, 2009. ,
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients, International Journal of Antimicrobial Agents, vol.39, pp.332-339, 2012. ,
Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?, Critical Care, vol.17, p.84, 2013. ,
Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission, Antimicrobial Agents and Chemotherapy, vol.53, pp.4483-4492, 2009. ,
Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility, Critical Care Medicine, vol.41, pp.489-95, 2013. ,
Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials, PloS One, vol.12, p.180247, 2017. ,
Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: a preliminary study, Critical Care & Pain Medicine, 2017. ,
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1), Critical Care, vol.17, p.204, 2013. ,
Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization, Current Opinion in Pharmacology, vol.24, pp.1-6, 2015. ,
The importance of empiric antibiotic dosing in critically ill trauma patients: Are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates?, Journal of Trauma and Acute Care Surgery, vol.81, pp.1115-1136, 2016. ,
Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients, Critical Care, vol.16, p.107, 2012. ,
Does augmented creatinine clearance accurately reflect glomerular hyperfiltration in critical illness?, Critical Care Medicine, vol.42, pp.674-679, 2014. ,
Impact of imipenem and amikacin pharmacokinetic/pharmacodynamic parameters on microbiological outcome of Gram-negative bacilli ventilator-associated pneumonia, The Journal of antimicrobial chemotherapy, vol.70, pp.1487-94, 2015. ,
Augmented renal clearance in critical illness, Minerva Anestesiologica, vol.81, pp.1050-1052, 2015. ,
Severe sepsis and septic shock, New England Journal of Medicine, vol.369, p.2063, 2013. ,
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Intensive care medicine, vol.39, pp.165-228, 2012. ,
Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study, American Journal of Respiratory and Critical Care Medicine, vol.180, pp.861-867, 2009. ,
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story, Anaesthesia and Intensive Care, vol.39, pp.999-1000, 2011. ,
Diagnostic microbiologique des infections bronchopulmonaires, Société francaise de microbiologie, p.97, 1995. ,